Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126900431 | 12690043 | 1 | I | 20160811 | 20160826 | 20160826 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-122687 | RANBAXY | 0.00 | M | Y | 0.00000 | 20160826 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126900431 | 12690043 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 85 MG/M2 EVERY 14 DAY CYCLE | 202922 | ||||||||||
126900431 | 12690043 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 20 MG, BID | AD2761Q | 0 | 20 | MG | TABLET | Q12H | |||||
126900431 | 12690043 | 3 | SS | ARANESP | DARBEPOETIN ALFA | 1 | Unknown | UNK | U | 0 | |||||||||
126900431 | 12690043 | 4 | C | CAPECITABINE. | CAPECITABINE | 1 | Unknown | UNK | U | 0 | |||||||||
126900431 | 12690043 | 5 | C | XELODA | CAPECITABINE | 1 | Unknown | 1500 MG, BID (ONE WEEK ON AND ONE WEEK OFF) | U | 0 | 1500 | MG | Q12H |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126900431 | 12690043 | 1 | Product used for unknown indication |
126900431 | 12690043 | 2 | Myelofibrosis |
126900431 | 12690043 | 3 | Product used for unknown indication |
126900431 | 12690043 | 4 | Product used for unknown indication |
126900431 | 12690043 | 5 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126900431 | 12690043 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126900431 | 12690043 | Abdominal discomfort | |
126900431 | 12690043 | Anaemia | |
126900431 | 12690043 | Arthralgia | |
126900431 | 12690043 | Balance disorder | |
126900431 | 12690043 | Decreased appetite | |
126900431 | 12690043 | Dyspnoea | |
126900431 | 12690043 | Early satiety | |
126900431 | 12690043 | Malaise | |
126900431 | 12690043 | Neuropathy peripheral | |
126900431 | 12690043 | Oedema peripheral | |
126900431 | 12690043 | Weight decreased | |
126900431 | 12690043 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126900431 | 12690043 | 1 | 20160415 | 0 | ||
126900431 | 12690043 | 2 | 20160205 | 0 | ||
126900431 | 12690043 | 5 | 201603 | 0 |